Items Tagged ‘John (Jay) Bergquist’
March 15, 2016 · Leave a Comment
New Treatment-Sequencing Based on Biomarker Elevation in Pancreatic Cancer
Pancreatic cancer is the fourth leading cause of death in men and women and is projected to increase to the second leading cause of death by 2020 if there are not significant treatment advances made. Our current understanding of pancreatic cancer suggests that it is a systemic disease in most patients, meaning, that by the time of […]
View full entry Comment on this
Tags: biomarkers, Center for the Science of Health Care Delivery, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, pancreatic cancer, surgery, surgical outcomes
November 10, 2015
CA 19-9 tumor marker test especially important for early-stage patients, Mayo finds Only 1 in 5 U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a Mayo Clinic study shows. […]
Tags: Carlos Puig, Center for the Science of Health Care Delivery, Christopher Shubert, David Nagorney, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, Michael Farnell, Michael Kendrick, pancreatic cancer, Rory Smoot, Ryan Groeschl